Acticor Biotech’s IPO

McDermott has advised Acticor Biotech on the offering. Acticor Biotech, a clinical stage biopharmaceutical company dedicated to developing a drug for the treatment of cardiovascular emergencies,...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Forsee Power’s IPO

Orrick advised Ballard Power Systems, Jones Day and Valther advised Forsee Power, Cleary Gottlieb advised the banks, UGGC Avocats advised BpiFrance. Dentons advised Mitsui, White & Case...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here